Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ironside Ventures is a Cambridge-based venture capital firm specializing in early-stage investments within the life sciences, biotechnology, and healthcare technology sectors. The firm was founded by Robert Higgins, a veteran venture capitalist and former co-founder of Highland Capital Partners, to support transformative companies emerging from the Boston-Cambridge innovation ecosystem. Ironside Ventures typically provides seed and Series A funding to startups developing novel therapeutics, diagnostics, and digital health solutions. Notable portfolio investments include companies such as Spero Therapeutics and Celsius Therapeutics, highlighting the firm's focus on high-impact medical innovations. By combining capital with strategic mentorship, the firm aims to bridge the gap between academic discovery and commercial clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ironside Ventures.